You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Oxford Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for OXFORD PHARMS, and what generic and branded alternatives to OXFORD PHARMS drugs are available?

OXFORD PHARMS has thirty-five approved drugs.

Summary for Oxford Pharms
US Patents:0

Drugs and US Patents for Oxford Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040706-003 Feb 14, 2008 DISCN No No   Start Trial   Start Trial
Oxford Pharms RISPERIDONE risperidone TABLET;ORAL 078071-003 Jun 17, 2009 AB RX No No   Start Trial   Start Trial
Oxford Pharms BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 075388-002 May 9, 2002 DISCN No No   Start Trial   Start Trial
Oxford Pharms SPIRONOLACTONE spironolactone TABLET;ORAL 040750-003 Aug 29, 2006 AB RX No No   Start Trial   Start Trial
Oxford Pharms LEVETIRACETAM levetiracetam TABLET;ORAL 077319-003 Mar 20, 2009 AB RX No No   Start Trial   Start Trial
Oxford Pharms HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 087059-001 Approved Prior to Jan 1, 1982 AB RX No No   Start Trial   Start Trial
Oxford Pharms SOTALOL HYDROCHLORIDE sotalol hydrochloride TABLET;ORAL 075563-002 Nov 7, 2003 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.